GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $89,485,000 | -0.7% | 2,055,749 | -0.6% | 0.03% | +13.0% |
| Q1 2022 | $90,110,000 | -1.8% | 2,068,672 | -0.5% | 0.02% | +9.5% |
| Q4 2021 | $91,717,000 | +8.6% | 2,079,764 | -5.9% | 0.02% | -4.5% |
| Q3 2021 | $84,417,000 | +3.3% | 2,209,267 | +7.6% | 0.02% | 0.0% |
| Q2 2021 | $81,727,000 | -76.5% | 2,052,416 | -79.0% | 0.02% | -78.2% |
| Q1 2021 | $348,227,000 | -35.7% | 9,757,031 | -33.7% | 0.10% | -35.7% |
| Q4 2020 | $541,391,000 | -7.6% | 14,711,762 | -5.5% | 0.16% | -24.9% |
| Q3 2020 | $585,852,000 | -14.4% | 15,564,595 | -7.2% | 0.21% | -22.9% |
| Q2 2020 | $684,025,000 | +4.9% | 16,769,411 | -2.6% | 0.27% | -13.7% |
| Q1 2020 | $652,315,000 | +43.6% | 17,215,994 | +78.1% | 0.31% | +91.5% |
| Q4 2019 | $454,192,000 | +7.4% | 9,665,720 | -2.4% | 0.16% | -1.8% |
| Q3 2019 | $422,722,000 | -5.0% | 9,904,400 | -10.9% | 0.17% | -6.7% |
| Q2 2019 | $444,940,000 | -5.5% | 11,117,947 | -1.3% | 0.18% | -10.9% |
| Q1 2019 | $470,810,000 | -27.1% | 11,266,113 | -33.4% | 0.20% | -35.2% |
| Q4 2018 | $645,925,000 | -19.5% | 16,904,618 | -15.4% | 0.31% | -7.2% |
| Q3 2018 | $802,600,000 | -5.0% | 19,980,096 | -4.7% | 0.33% | -12.1% |
| Q2 2018 | $845,137,000 | +1.6% | 20,965,939 | -1.5% | 0.38% | +1.9% |
| Q1 2018 | $831,903,000 | -8.2% | 21,292,590 | -16.6% | 0.37% | -6.3% |
| Q4 2017 | $905,879,000 | +158.1% | 25,539,319 | +195.4% | 0.40% | +135.5% |
| Q3 2017 | $350,966,000 | -10.1% | 8,644,505 | -4.5% | 0.17% | -16.3% |
| Q2 2017 | $390,300,000 | +6.0% | 9,051,485 | +3.7% | 0.20% | +1.5% |
| Q1 2017 | $368,137,000 | +13.3% | 8,731,884 | +3.5% | 0.20% | +12.4% |
| Q4 2016 | $325,022,000 | -11.9% | 8,439,889 | -1.3% | 0.18% | -14.9% |
| Q3 2016 | $368,918,000 | -6.8% | 8,553,640 | -6.3% | 0.21% | -11.5% |
| Q2 2016 | $395,669,000 | +8.9% | 9,129,435 | +1.9% | 0.24% | +4.0% |
| Q1 2016 | $363,357,000 | -23.1% | 8,960,757 | -23.5% | 0.23% | -27.3% |
| Q4 2015 | $472,556,000 | +12.9% | 11,711,477 | +7.6% | 0.31% | -0.6% |
| Q3 2015 | $418,539,000 | -13.8% | 10,885,295 | -6.6% | 0.31% | -6.6% |
| Q2 2015 | $485,311,000 | -12.2% | 11,652,110 | -2.8% | 0.34% | -13.2% |
| Q1 2015 | $553,018,000 | -6.5% | 11,983,052 | -13.4% | 0.39% | +1.0% |
| Q4 2014 | $591,554,000 | -5.4% | 13,840,760 | +1.7% | 0.38% | -10.7% |
| Q3 2014 | $625,408,000 | -17.1% | 13,604,670 | -3.6% | 0.43% | -16.2% |
| Q2 2014 | $754,728,000 | +0.1% | 14,112,351 | +0.1% | 0.51% | -7.6% |
| Q1 2014 | $753,603,000 | -21.3% | 14,104,467 | -21.4% | 0.55% | -18.7% |
| Q4 2013 | $957,922,000 | +5.9% | 17,941,969 | -0.5% | 0.68% | -2.2% |
| Q3 2013 | $904,289,000 | -0.1% | 18,024,481 | -0.5% | 0.70% | -9.4% |
| Q2 2013 | $905,612,000 | – | 18,123,087 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |